Data Insights
By Company Name
No Filter Selected
By Disease Name
No Filter Selected
By Drug Name
No Filter Selected
By Themes
No Filter Selected
Showing 1 results out of 1
Data Insights
MK-1167 by Merck for Dementia Associated With Alzheimer's Disease: Likelihood of Approval
MK-1167 is under clinical development by Merck and currently in Phase I for Dementia Associated With Alzheimer's Disease. According to...